One of the largest listed healthcare REIT in Asian region with an enlarged portfolio of S$1.6 billion.
Core Strengths:
Defensive long term lease structure with downside protection
Stable income stream supported by regular rental revision
Diversified portfolio of high quality and yield accretive properties
Well-positioned in fast growing healthcare sector within the Asia-Pacific region
ParkwayLife Reit after hitting the low os 2.08 on 16th Feb 2016 it had managed to stage a strong recovery and head higher to touch 2.50 on 28th April 2016.
The current price of 2.49 is staying above the SMA lines which is generally rather positive.
Also both Macd & Rsi are still rising which may provide further catalyst that the share price may continue to trend higher.
Short term wise it may continue to trend higher to test 2.60. Breaking out of 2.60 with good volume that may propel to drive the share price higher towards 2.70 with extension to 2.79.
It pays out DPU every quarter. Each quarter is about 3.35 cents which may add up a total of 13.35 cents. Yield is about 5.3%.
(trade base on your own decision)
Investing in share market for capital growth will be more successful if you follow Epic Research.
ReplyDelete